Sign in

You're signed outSign in or to get full access.

AC

AMREP CORP. (AXR)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 FY2025 revenue was $7.52M and diluted EPS was $0.13; net income rose to $0.717M vs $0.092M YoY despite lower revenue, reflecting higher profitability on fewer transactions .
  • Sequentially, revenue declined vs Q2 ($11.91M) and Q1 ($19.09M); EPS fell from $0.75 (Q2) and $0.76 (Q1) to $0.13 (Q3), consistent with management’s reminder that quarterly results can vary significantly due to the timing and mix of land/home sales .
  • No formal guidance was provided in the Q3 materials; management directed investors to the concurrently filed 10-Q for further detail .
  • No earnings call transcript was available for Q3 FY2025, limiting qualitative color and specific drivers of quarterly variability [List: earnings-call-transcript search returned none; see documents listed above].

What Went Well and What Went Wrong

What Went Well

  • Strong YoY EPS expansion: diluted EPS rose to $0.13 from $0.02 despite lower revenue, indicating improved profitability per share in the quarter .
  • Year-to-date momentum: for the first nine months of FY2025, revenue was $38.52M vs $31.83M and diluted EPS was $1.64 vs $0.48 YoY, demonstrating substantial progress through FY2025 .
  • Management underscores portfolio strength and operating capabilities in New Mexico as a “major holder of land, leading developer… and award-winning homebuilder,” reinforcing strategic positioning for future transactions .

What Went Wrong

  • Quarterly revenue volatility: Q3 revenue fell to $7.52M from $11.91M in Q2 and $19.09M in Q1, highlighting inherent lumpiness driven by deal timing and product mix .
  • EPS normalization: diluted EPS decreased to $0.13 from $0.75 (Q2) and $0.76 (Q1), reflecting fewer or smaller transactions closed in Q3 vs earlier FY2025 quarters .
  • Limited disclosure and no guidance: Q3 press release offered headline financials but no segment/margin detail or forward guidance; management cautioned results “can vary significantly from period to period” given transaction timing, leaving less visibility for near-term modeling .

Financial Results

MetricQ3 2024Q1 2025Q2 2025Q3 2025
Revenue ($USD Millions)$12.69 $19.09 $11.91 $7.52
Net Income ($USD Millions)$0.09 $4.06 $4.04 $0.72
Diluted EPS ($)$0.02 $0.76 $0.75 $0.13
Weighted Avg Diluted Shares (Millions)5.35 5.35 5.37 5.38

Notes:

  • Q3 FY2025 ended January 31, 2025; comparisons are to the same quarter prior year and sequentially to Q2 and Q1 FY2025 .
  • No margin, segment, or KPI detail was disclosed in the press release/8-K exhibits .

Segment breakdown: Not disclosed in Q3 press release/8-K .

KPIs: Not disclosed in Q3 press release/8-K .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Company GuidanceFY2025/Q4 and FY2026Not providedNot providedMaintained (no formal guidance)

Management referenced the filed 10-Q for details but did not issue quantitative guidance ranges in the Q3 materials .

Earnings Call Themes & Trends

No earnings call transcript was available for Q3 FY2025, and no prior quarter transcripts were found in the document catalog. As a result, thematic tracking across Q1–Q3 FY2025 is unavailable.

TopicPrevious Mentions (Q1 FY2025)Previous Mentions (Q2 FY2025)Current Period (Q3 FY2025)Trend
AI/Technology InitiativesNo transcript availableNo transcript availableNo transcript availablen/a
Supply ChainNo transcript availableNo transcript availableNo transcript availablen/a
Tariffs/MacroNo transcript availableNo transcript availableNo transcript availablen/a
Product/Regional PerformanceNo transcript availableNo transcript availableNo transcript availablen/a
Regulatory/LegalNo transcript availableNo transcript availableNo transcript availablen/a

Management Commentary

  • “More information about the Company’s financial performance may be found in AMREP Corporation’s financial statements on Form 10-Q… As a result of many factors… revenues, average selling prices and related gross margins… can vary significantly from period to period…” — Q3 press release and 8-K exhibit .
  • Strategic positioning: AMREP describes itself as a “major holder of land, leading developer of real estate and award-winning homebuilder in New Mexico,” underscoring local scale advantages and operating expertise .

Q&A Highlights

No Q&A available; an earnings call transcript was not found for Q3 FY2025 in the document catalog, so no analyst questions or clarifications can be summarized for this quarter.

Estimates Context

  • We attempted to retrieve Wall Street consensus via S&P Global for Q3 FY2025 (EPS and revenue), but data access failed due to daily request limits; therefore, estimate comparisons are unavailable. If estimates become accessible, we will anchor comparisons on S&P Global consensus and highlight any beats/misses. Values would be retrieved from S&P Global.

Key Takeaways for Investors

  • Quarter-to-quarter results are inherently lumpy; Q3 revenue ($7.52M) and EPS ($0.13) declined sequentially after very strong Q1–Q2, in line with management’s caution on timing/mix sensitivity .
  • Despite lower Q3 revenue, YoY profitability expanded meaningfully (EPS $0.13 vs $0.02; net income $0.717M vs $0.092M), implying improved margin economics or mix on closed transactions .
  • Year-to-date performance remains robust (9M FY2025 revenue $38.52M; diluted EPS $1.64), supporting the medium-term thesis around monetization of the New Mexico asset base .
  • Lack of formal guidance increases near-term modeling uncertainty; monitor upcoming filings or management communications for backlog, land sale pipeline, and home closing cadence .
  • Trading: shares may react to quarterly variability headlines; focus on deal flow visibility and any forthcoming land/home sale announcements as catalysts.
  • Thesis: leverage to periodic large transactions suggests potential for episodic upside; position sizing should reflect volatility in quarterly prints and information flow.